504 related articles for article (PubMed ID: 23239541)
1. A 137-kb deletion within the Potocki-Shaffer syndrome interval on chromosome 11p11.2 associated with developmental delay and hypotonia.
Montgomery ND; Turcott CM; Tepperberg JH; McDonald MT; Aylsworth AS
Am J Med Genet A; 2013 Jan; 161A(1):198-202. PubMed ID: 23239541
[TBL] [Abstract][Full Text] [Related]
2. The first Korean patient with Potocki-Shaffer syndrome: a rare cause of multiple exostoses.
Sohn YB; Yim SY; Cho EH; Kim OH
J Korean Med Sci; 2015 Feb; 30(2):214-7. PubMed ID: 25653495
[TBL] [Abstract][Full Text] [Related]
3. A microdeletion encompassing PHF21A in an individual with global developmental delay and craniofacial anomalies.
Labonne JD; Vogt J; Reali L; Kong IK; Layman LC; Kim HG
Am J Med Genet A; 2015 Dec; 167A(12):3011-8. PubMed ID: 26333423
[TBL] [Abstract][Full Text] [Related]
4. Potocki-Shaffer syndrome in a child without intellectual disability-The role of PHF21A in cognitive function.
McCool C; Spinks-Franklin A; Noroski LM; Potocki L
Am J Med Genet A; 2017 Mar; 173(3):716-720. PubMed ID: 28127865
[TBL] [Abstract][Full Text] [Related]
5. Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies.
Kim HG; Kim HT; Leach NT; Lan F; Ullmann R; Silahtaroglu A; Kurth I; Nowka A; Seong IS; Shen Y; Talkowski ME; Ruderfer D; Lee JH; Glotzbach C; Ha K; Kjaergaard S; Levin AV; Romeike BF; Kleefstra T; Bartsch O; Elsea SH; Jabs EW; MacDonald ME; Harris DJ; Quade BJ; Ropers HH; Shaffer LG; Kutsche K; Layman LC; Tommerup N; Kalscheuer VM; Shi Y; Morton CC; Kim CH; Gusella JF
Am J Hum Genet; 2012 Jul; 91(1):56-72. PubMed ID: 22770980
[TBL] [Abstract][Full Text] [Related]
6. De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies.
Hamanaka K; Sugawara Y; Shimoji T; Nordtveit TI; Kato M; Nakashima M; Saitsu H; Suzuki T; Yamakawa K; Aukrust I; Houge G; Mitsuhashi S; Takata A; Iwama K; Alkanaq A; Fujita A; Imagawa E; Mizuguchi T; Miyake N; Miyatake S; Matsumoto N
Eur J Hum Genet; 2019 Mar; 27(3):378-383. PubMed ID: 30487643
[TBL] [Abstract][Full Text] [Related]
7. Hypertension in Potocki-Shaffer syndrome: A case report.
Wissman SD; McCool C; Potocki L; Elenberg E
Eur J Med Genet; 2020 Jan; 63(1):103633. PubMed ID: 30797056
[TBL] [Abstract][Full Text] [Related]
8. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
9. 11p11.12p12 duplication in a family with intellectual disability and craniofacial anomalies.
Chen X; Xu H; Shi W; Wang F; Xu F; Zhang Y; Gan J; Tian X; Chen B; Dai M
BMC Med Genomics; 2021 Apr; 14(1):99. PubMed ID: 33836758
[TBL] [Abstract][Full Text] [Related]
10. Potocki-Shaffer syndrome: comprehensive clinical assessment, review of the literature, and proposals for medical management.
Swarr DT; Bloom D; Lewis RA; Elenberg E; Friedman EM; Glotzbach C; Wissman SD; Shaffer LG; Potocki L
Am J Med Genet A; 2010 Mar; 152A(3):565-72. PubMed ID: 20140962
[TBL] [Abstract][Full Text] [Related]
11. Potocki-Shaffer deletion encompassing ALX4 in a patient with frontonasal dysplasia phenotype.
Ferrarini A; Gaillard M; Guerry F; Ramelli G; Heidi F; Keddache CV; Wieland I; Beckmann JS; Jaquemont S; Martinet D
Am J Med Genet A; 2014 Feb; 164A(2):346-52. PubMed ID: 24376213
[TBL] [Abstract][Full Text] [Related]
12. Construction of a natural panel of 11p11.2 deletions and further delineation of the critical region involved in Potocki-Shaffer syndrome.
Wakui K; Gregato G; Ballif BC; Glotzbach CD; Bailey KA; Kuo PL; Sue WC; Sheffield LJ; Irons M; Gomez EG; Hecht JT; Potocki L; Shaffer LG
Eur J Hum Genet; 2005 May; 13(5):528-40. PubMed ID: 15852040
[TBL] [Abstract][Full Text] [Related]
13.
Butera A; Nicotera AG; Di Rosa G; Musumeci SA; Vitello GA; Musumeci A; Vinci M; Gloria A; Federico C; Saccone S; Calì F
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555772
[No Abstract] [Full Text] [Related]
14. Identification of a 6-month-old baby with a combination of WAGR and Potocki-Shaffer contiguous deletion syndromes by SNP array testing.
Meng Y; Yang J; Tian C; Qiao J
Hereditas; 2020 May; 157(1):23. PubMed ID: 32446308
[TBL] [Abstract][Full Text] [Related]
15. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
[TBL] [Abstract][Full Text] [Related]
16. New Insights into Potocki-Shaffer Syndrome: Report of Two Novel Cases and Literature Review.
Trajkova S; Di Gregorio E; Ferrero GB; Carli D; Pavinato L; Delplancq G; Kuentz P; Brusco A
Brain Sci; 2020 Oct; 10(11):. PubMed ID: 33126574
[TBL] [Abstract][Full Text] [Related]
17. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
[TBL] [Abstract][Full Text] [Related]
18. Combination of WAGR and Potocki-Shaffer contiguous deletion syndromes in a patient with an 11p11.2-p14 deletion.
Brémond-Gignac D; Crolla JA; Copin H; Guichet A; Bonneau D; Taine L; Lacombe D; Baumann C; Benzacken B; Verloes A
Eur J Hum Genet; 2005 Apr; 13(4):409-13. PubMed ID: 15702131
[TBL] [Abstract][Full Text] [Related]
19. Interstitial deletion 11(p11.12p11.2) and analphoid marker formation results in inherited Potocki-Shaffer syndrome.
Chuang L; Wakui K; Sue WC; Su MH; Shaffer LG; Kuo PL
Am J Med Genet A; 2005 Mar; 133A(2):180-3. PubMed ID: 15666301
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome Analysis Revealed Impaired cAMP Responsiveness in PHF21A-Deficient Human Cells.
Porter RS; Murata-Nakamura Y; Nagasu H; Kim HG; Iwase S
Neuroscience; 2018 Feb; 370():170-180. PubMed ID: 28571721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
